Alyeska Investment Group
SPRY icon

Alyeska Investment Group’s ARS Pharmaceuticals SPRY Stock Holding History

Alyeska Investment Group’s Portfolio SPRY Stock Details SPRY Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
2025
Q4 		$4.88M Buy
2025
Q3 		$3.92M Buy
2025
Q2 		$5.06M Hold
2025
Q1 		$3.65M Sell
2024
Q4 		$13.2M Buy
2024
Q3 		$1.81M Buy
2021
Q2 		– Sell
2021
Q1 		$1.09M Hold
2020
Q4 		$1.16M Buy